Literature DB >> 26041038

Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis.

Neil M Ampel1, Lance A Nesbit2, Chinh T Nguyen3, Suzette Chavez3, Kenneth S Knox4, Suzanne M Johnson5, Demosthenes Pappagianis5.   

Abstract

The outcome of coccidioidomycosis depends on a robust specific cellular immune response. A T-helper type 1 (Th1) cellular immune response has been previously associated with resolution of clinical illness. However, the precise elements of this response and whether cytokines not involved with the Th1 response play a role in coccidioidomycosis are not known. Whole-blood samples were obtained from subjects with active coccidioidomycosis and controls and incubated for 18 h with T27K, a coccidioidal antigen preparation. The supernatant was then assayed for gamma interferon (IFN-γ), interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-α), IL-4, IL-6, IL-10, and IL-17A. A total of 43 subjects, 16 with acute pneumonia, 9 with pulmonary sequelae of nodules and cavities, and 18 with nonmeningeal disseminated coccidioidomycosis, were studied. Compared to concentrations in healthy immune and nonimmune donors, the median concentration of IL-17A was significantly higher in those with active coccidioidomycosis (for both, P < 0.01). In addition, IL-6 concentrations were higher while IL-2 and IFN-γ concentrations were significantly lower in those with nonmeningeal disseminated disease diagnosed within 12 months than in those with acute pneumonia (for all, P < 0.05). The cytokine profile among patients with active coccidioidomycosis is distinct in that IL-17A is persistently present. In addition, those with nonmeningeal disseminated disease have an increased inflammatory cytokine response and diminished Th1 responses that modulate over time.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26041038      PMCID: PMC4519718          DOI: 10.1128/CVI.00280-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  20 in total

1.  An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.

Authors:  Neil M Ampel; Richard F Hector; Christina P Lindan; George W Rutherford
Journal:  Mycopathologia       Date:  2006-02       Impact factor: 2.574

Review 2.  Coccidioidomycosis. Part I.

Authors:  D J Drutz; A Catanzaro
Journal:  Am Rev Respir Dis       Date:  1978-03

3.  Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood.

Authors:  N M Ampel; L A Kramer; K M Kerekes; S M Johnson; D Pappagianis
Journal:  Med Mycol       Date:  2001-08       Impact factor: 4.076

Review 4.  Serologic studies in coccidioidomycosis.

Authors:  D Pappagianis
Journal:  Semin Respir Infect       Date:  2001-12

5.  Comparison of immunodiffusion techniques with standard complement fixation assay for quantitation of coccidioidal antibodies.

Authors:  M A Wieden; J N Galgiani; D Pappagianis
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

6.  Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.

Authors:  Neil M Ampel; Daniel K Nelson; Suzette Chavez; Kathryn A Naus; Amanda B Herman; Lijin Li; Keira A Simmons; Demosthenes Pappagianis
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

7.  In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.

Authors:  Neil M Ampel; Larissa A Kramer; Lijin Li; Deborah S Carroll; Kathleen M Kerekes; Suzanne M Johnson; Demosthenes Pappagianis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 8.  Epidemiology of coccidioidomycosis.

Authors:  D Pappagianis
Journal:  Curr Top Med Mycol       Date:  1988

Review 9.  The complex immunology of human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Ann N Y Acad Sci       Date:  2007-03-15       Impact factor: 5.691

10.  Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people.

Authors:  H Bruunsgaard; S Ladelund; A N Pedersen; M Schroll; T Jørgensen; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

View more
  6 in total

Review 1.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

Review 2.  Immune Response to Coccidioidomycosis and the Development of a Vaccine.

Authors:  Natalia Castro-Lopez; Chiung-Yu Hung
Journal:  Microorganisms       Date:  2017-03-16

3.  Risk Factors for Disseminated Coccidioidomycosis, United States.

Authors:  Camila D Odio; Beatriz E Marciano; John N Galgiani; Steven M Holland
Journal:  Emerg Infect Dis       Date:  2017-02       Impact factor: 6.883

Review 4.  Coccidioidomycosis: Changing Concepts and Knowledge Gaps.

Authors:  Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2020-12-10

5.  Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies.

Authors:  Zengzheng Li; Zefeng Yang; Peng Hu; Xin Guan; Lihua Zhang; Jinping Zhang; Tonghua Yang; Chaoran Zhang; Renbin Zhao
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

6.  Ex Vivo Cytokine Release, Determined by a Multiplex Cytokine Assay, in Response to Coccidioidal Antigen Stimulation of Whole Blood among Subjects with Recently Diagnosed Primary Pulmonary Coccidioidomycosis.

Authors:  Neil M Ampel; Ian Robey; Chinh T Nguyen; Brentin Roller; Jessica August; Kenneth S Knox; Demosthenes Pappagianis
Journal:  mSphere       Date:  2018-05-16       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.